BioPharm News

Jul 09, 2008
BioPharm International
By BioPharm International Editors
Intas Biopharmaceuticals Limited (IBPL, Ahmedabad, India) has acquired the US-based biotechnology corporation, Biologics Process Development Incorporated (BPD Inc., Poway, CA).
Jul 09, 2008
BioPharm International
By BioPharm International Editors
French biopharmaceutical company Trophos SA (Marseille, France) has appointed Damian Marron as chief executive officer.
Jun 11, 2008
BioPharm International
By BioPharm International Editors
Bavarian Nordic, (Kvistgaard, Denmark), has initiated a Phase 1–2 clinical study with its HIV vaccine candidate, MVA-BN HIV multiantigen.
Jun 11, 2008
BioPharm International
By BioPharm International Editors
The global biotechnology industry achieved record levels in financing and deal making in 2007, as investors and strategic partners showed strong confidence in the sector amid tightening global financial conditions that will continue to test the industry in 2008.
Jun 11, 2008
BioPharm International
By BioPharm International Editors
WuXi PharmaTech (Shanghai, China) has appointed Peng Wang, PhD as vice president of discovery biology.
Jun 11, 2008
BioPharm International
By BioPharm International Editors
The US Pharmacopeial (USP) Convention (Rockville, MD) has announced updates to the guideline for its pending monographs approach.
Jun 11, 2008
BioPharm International
By BioPharm International Editors
SciLog, Inc. (Middleton, WI), a privately held company that designs and manufactures computer-controlled bioprocessing equipment, has announced the signing of a patent licensing agreement with GE Healthcare (Somerset, NJ).
Jun 11, 2008
BioPharm International
By BioPharm International Editors
Daiichi Sankyo Co., Ltd. (Tokyo, Japan) will acquire U3 Pharma AG (Martinsried, Germany), a German biotechnology company focusing on research into antibodies for the treatment of cancer.
Jun 11, 2008
BioPharm International
By BioPharm International Editors
The US Food and Drug Administration (FDA) has granted Fast Track designation to Wyeth Pharmaceuticals’ (Collegeville, PA) investigational 13-valent pneumococcal conjugate vaccine for infants and toddlers.
Jun 11, 2008
BioPharm International
By BioPharm International Editors
Curtis (Curt) Rosebraugh, MD, has been appointed as the new director of the US Food and Drug Administration’s (FDA) Office of Drug Evaluation II.
native1_300x100
lorem ipsum